Mark D. Hicar, Ph.D. - Publications

Affiliations: 
2002 Ohio State University, Columbus, Columbus, OH 
Area:
Immunology, Molecular Biology

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Klug G, Cole FM, Hicar MD, Watt C, Peters T, Pincus SH. Identification of Anti-gp41 Monoclonal Antibodies That Effectively Target Cytotoxic Immunoconjugates to Cells Infected with Human Immunodeficiency Virus, Type 1. Vaccines. 11. PMID 37112741 DOI: 10.3390/vaccines11040829  0.449
2022 DeCotes D, Baron S, Hoffman J, Garrett M, Sojar H, Hicar MD. Highly mutated monoclonal antibody 3F2 targets a conformational and strain-restricted epitope in human immunodeficiency virus gp41 with significant antibody-dependent cell cytotoxicity. Archives of Virology. PMID 35871426 DOI: 10.1007/s00705-022-05518-3  0.458
2022 Wrotniak BH, Garrett M, Baron S, Sojar H, Shon A, Asiago-Reddy E, Yager J, Kalams S, Croix M, Hicar MD. Antibody dependent cell cytotoxicity is maintained by the unmutated common ancestor of 6F5, a Gp41 conformational epitope targeting antibody that utilizes heavy chain VH1-2. Vaccine. 40: 4174-4181. PMID 35688727 DOI: 10.1016/j.vaccine.2022.05.083  0.379
2022 Chang AJ, Baron S, Hoffman J, Hicar MD. Clonal expansion and markers of directed mutation of IGHV4-34 B cells in plasmablasts during Kawasaki disease. Molecular Immunology. 145: 67-77. PMID 35303530 DOI: 10.1016/j.molimm.2022.03.011  0.354
2021 Monteiro A, Yu KOA, Hicar MD. Peptide-based Fusion Inhibitors for Preventing the Six-helix Bundle Formation of Class I Fusion Proteins: HIV and Beyond. Current Hiv Research. PMID 34503415 DOI: 10.2174/1570162X19666210908115231  0.303
2020 Hicar MD. Antibodies and Immunity During Kawasaki Disease Frontiers in Cardiovascular Medicine. 7: 94. PMID 32671098 DOI: 10.3389/Fcvm.2020.00094  0.417
2019 Shao S, Huang WC, Lin C, Hicar MD, LaBranche CC, Montefiori DC, Lovell JF. An Engineered Biomimetic MPER Peptide Vaccine Induces Weakly HIV Neutralizing Antibodies in Mice. Annals of Biomedical Engineering. PMID 31832930 DOI: 10.1007/S10439-019-02398-8  0.505
2019 Sojar H, Baron S, Sullivan JT, Garrett M, van Haaren MM, Hoffman J, Overbaugh J, Doranz BJ, Hicar MD. Monoclonal antibody 2C6 targets cross-clade conformational epitope in gp41 with highly active antibody dependent cell cytotoxicity. Journal of Virology. PMID 31217246 DOI: 10.1128/Jvi.00772-19  0.507
2019 Lindquist ME, Hicar MD. B Cells and Antibodies in Kawasaki Disease. International Journal of Molecular Sciences. 20. PMID 31013925 DOI: 10.3390/Ijms20081834  0.755
2019 Smith M, Hoffman J, Sojar H, Aalinkeel R, Hsiao CB, Hicar MD. Assessment of Antibody Interference of Enfuvirtide (T20) Function Shows Assay Dependent Variability. Current Hiv Research. PMID 30836922 DOI: 10.2174/1570162X17666190228154850  0.455
2019 Baron S, Sojar HT, Hicar MD. 406. Cloning Antibodies Against Kawasaki Disease from Acute Plasmablast Responses Open Forum Infectious Diseases. 6. DOI: 10.1093/Ofid/Ofz360.479  0.424
2018 Martin M, Wrotniak BH, Hicar M. Suppressed plasmablast responses in febrile infants, including children with Kawasaki disease. Plos One. 13: e0193539. PMID 29579044 DOI: 10.1371/Journal.Pone.0193539  0.308
2018 Baron S, Sojar H, Hoffman J, Hicar M. 641. Development of Structural Epitope Targeting During B-cell Ontogeny by Exploration of Relatives of Gp41 Structural Epitope Binding Antibody 6F5 Open Forum Infectious Diseases. 5. DOI: 10.1093/Ofid/Ofy210.648  0.489
2016 Hicar MD, Chen X, Sulli C, Barnes T, Goodman J, Sojar H, Briney B, Willis J, Chukwuma VU, Kalams SA, Doranz BJ, Spearman P, Crowe JE. Human Antibodies that Recognize Novel Immunodominant Quaternary Epitopes on the HIV-1 Env Protein. Plos One. 11: e0158861. PMID 27411063 DOI: 10.1371/Journal.Pone.0158861  0.687
2015 Hicar MD, Chen X, Kalams SA, Sojar H, Landucci G, Forthal DN, Spearman P, Crowe JE. Low frequency of broadly neutralizing HIV antibodies during chronic infection even in quaternary epitope targeting antibodies containing large numbers of somatic mutations. Molecular Immunology. 70: 94-103. PMID 26748387 DOI: 10.1016/J.Molimm.2015.12.002  0.536
2015 Chukwuma VU, Hicar MD, Chen X, Nicholas KJ, Joyner A, Kalams SA, Landucci G, Forthal DN, Spearman PW, Crowe JE. Association of VH4-59 Antibody Variable Gene Usage with Recognition of an Immunodominant Epitope on the HIV-1 Gag Protein. Plos One. 10: e0133509. PMID 26226263 DOI: 10.1371/Journal.Pone.0133509  0.772
2014 Sojar H, Smith M, Hicar M. 1611Antibodies to conformational epitopes interfere with T20 fusion inhibition. Open Forum Infectious Diseases. 1. DOI: 10.1093/Ofid/Ofu052.1157  0.445
2013 Hicar MD. Immunotherapies to prevent mother-to-child transmission of HIV. Current Hiv Research. 11: 137-43. PMID 23432489 DOI: 10.2174/1570162X11311020006  0.335
2012 Briney BS, Willis JR, Hicar MD, Thomas JW, Crowe JE. Frequency and genetic characterization of V(DD)J recombinants in the human peripheral blood antibody repertoire. Immunology. 137: 56-64. PMID 22612413 DOI: 10.1111/J.1365-2567.2012.03605.X  0.757
2012 Yu X, Tsibane T, McGraw PA, House FS, Keefer CJ, Hicar MD, Tumpey TM, Pappas C, Perrone LA, Martinez O, Stevens J, Wilson IA, Aguilar PV, Altschuler EL, Basler CF, et al. Erratum: Corrigendum: Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors Nature. 490: 570-570. DOI: 10.1038/Nature11235  0.721
2011 Hicar MD, Edwards K, Bloch K. Powassan virus infection presenting as acute disseminated encephalomyelitis in Tennessee. The Pediatric Infectious Disease Journal. 30: 86-8. PMID 20736878 DOI: 10.1097/Inf.0B013E3181F2F492  0.323
2010 Hicar MD, Chen X, Briney B, Hammonds J, Wang JJ, Kalams S, Spearman PW, Crowe JE. Pseudovirion particles bearing native HIV envelope trimers facilitate a novel method for generating human neutralizing monoclonal antibodies against HIV. Journal of Acquired Immune Deficiency Syndromes (1999). 54: 223-35. PMID 20531016 DOI: 10.1097/Qai.0B013E3181Dc98A3  0.764
2010 Hicar MD, Kalams SA, Spearman PW, Crowe JE. Emerging studies of human HIV-specific antibody repertoires. Vaccine. 28: B18-23. PMID 20510738 DOI: 10.1016/J.Vaccine.2010.02.002  0.588
2008 Yu X, Tsibane T, McGraw PA, House FS, Keefer CJ, Hicar MD, Tumpey TM, Pappas C, Perrone LA, Martinez O, Stevens J, Wilson IA, Aguilar PV, Altschuler EL, Basler CF, et al. Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature. 455: 532-6. PMID 18716625 DOI: 10.1038/Nature07231  0.751
2002 Hicar MD, Robinson ML, Wu LC. Embryonic expression and regulation of the large zinc finger protein KRC. Genesis (New York, N.Y. : 2000). 33: 8-20. PMID 12001065 DOI: 10.1002/Gene.10084  0.567
2001 Wu LC, Hicar MD, Hong J, Allen CE. The DNA-binding ability of HIVEP3/KRC decreases upon activation of V(D)J recombination. Immunogenetics. 53: 564-71. PMID 11685469 DOI: 10.1007/S002510100360  0.72
2001 Hicar MD, Liu Y, Allen CE, Wu LC. Structure of the human zinc finger protein HIVEP3: molecular cloning, expression, exon-intron structure, and comparison with paralogous genes HIVEP1 and HIVEP2. Genomics. 71: 89-100. PMID 11161801 DOI: 10.1006/Geno.2000.6425  0.636
Show low-probability matches.